HIMS - Hims & Hers Health Shares Climb After News of Double-Digit Revenue Growth. Is It Too Late to Buy the Stock?
2024-05-11 03:15:00 ET
Shares of Hims & Hers Health (NYSE: HIMS) jumped following the company's first-quarter earnings report that once again announced surging revenue growth. That performance has helped the stock perform well this year, up about 40%.
Let's look at some recent comments from the CEO that caused the stock to dip, the company's recent quarterly results, and whether it's too late to buy the stock.
Hims & Hers CEO Andrew Dudum caused some controversy ahead of the company's earnings report when he came out on social media in support of pro-Palestinian college protests, while saying his company would be willing to hire the protesters.
For further details see:
Hims & Hers Health Shares Climb After News of Double-Digit Revenue Growth. Is It Too Late to Buy the Stock?